Across TCGA pan-cancer cohorts, RN7SKP287 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RN7SKP287 data layer.
The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RN7SKP287 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SKP287 expression acts as an unfavorable survival marker, although some lineages such as HNSC and READ show a favorable association.
STAD, ACC, and KIRC are the cancer types where RN7SKP287 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.